MOSCOW: Russian state technology firm Rusnano is teaming up with a US venture fund in a deal to invest around $760 million in a number of US healthcare technology companies, establish a manufacturing facility in Russia and bring new drugs to the Russian market.
As part of the deal, Rusnano and life sciences technologies investor Domain Associates are planning to co-invest in about 20 US-based healthcare technology companies.
Rusnano will invest up to $330 million while Domain's venture capital funds and other investors will invest a like amount, the companies said.
The remainder of the money will be used to establish a pharmaceutical and medical device manufacturing facility in Russia. At this facility, products will be manufactured that have been created by the companies the pair invest in.
Comments
Comments are closed for this article.